FGF21 and obesity due to melanocortin 4 receptor deficiency: The multiple beneficial effects of FGF21 on glucose and lipid metabolism and insulin sensitivity suggest that it might represent a promising therapeutic agent to treat diabetes and other obesity-related metabolic disorders (9,10).